BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/20/2022 11:01:13 AM | Browse: 217 | Download: 420
 |
Received |
|
2022-04-20 20:13 |
|
Peer-Review Started |
|
2022-04-20 20:17 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-05-30 04:21 |
|
Revised |
|
2022-06-14 00:24 |
|
Second Decision |
|
2022-08-09 02:55 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-08-11 04:35 |
|
Articles in Press |
|
2022-08-11 04:35 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-09-07 03:29 |
|
Publish the Manuscript Online |
|
2022-09-20 11:01 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Case Control Study |
| Article Title |
Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Slavica Minic Janicijevic, Ivan P Jovanovic, Nevena M Gajovic, Milena M Jurisevic, Monojit Debnath, Nebojsa N Arsenijevic and Milica M Borovcanin |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ministry of Science and Technological Development of the Republic of Serbia |
175069 |
| Faculty of Medical Sciences, University of Kragujevac |
JP15-05 |
|
| Corresponding Author |
Milica M Borovcanin, MD, PhD, Associate Professor, Department of Psychiatry, Faculty of Medical Sciences, University of Kragujevac, Svetozara Markovica 69, Kragujevac 34000, Serbia. milicaborovcanin@yahoo.com |
| Key Words |
Schizophrenia; Galectin-3; Cytokines; Leukocytes; Antipsychotics |
| Core Tip |
In clinical sampling, there is an urge to place the results of biological measurements in a much broader context. Elevated serum galectin-3 (Gal-3) levels in schizophrenia (SC) have not been studied in relation to other peripheral biomarkers and subsequent neuroinflammation. We found that Gal-3 contributes to ongoing peripheral systemic inflammation and disease duration in patients with SC. All of this may be an underlying indirect immunometabolic mechanism for cognitive performance in patients with SC. |
| Publish Date |
2022-09-20 11:01 |
| Citation |
Minic Janicijevic S, Jovanovic IP, Gajovic NM, Jurisevic MM, Debnath M, Arsenijevic NN, Borovcanin MM. Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognition. World J Psychiatry 2022; 12(9): 1183-1193 |
| URL |
https://www.wjgnet.com/2220-3206/full/v12/i9/1183.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v12.i9.1183 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
